99 items found

Tags: 110309 Infectious Diseases NCT Neuroscience Pharmacology

Filter Results
  • dataset

    Subjects’ characteristics.

    Δ changes over 12 weeks. BMI, Body Mass Index; FM, fat mass; FFM, fat free mass; PAL, physical activity level. These data concern the as analysed population and not the as...
  • dataset

    Regression models of unadjusted and adjusted age-adjusted z scores by study arm.

    Regression models of unadjusted and adjusted age-adjusted z scores by study arm.
  • dataset

    Patient Characteristics.

    Abbreviations: AML, acute myeloid leukemia; sAML, secondary AML; ALL, acute lymphoblastic leukemia; PMF, primary myelofibrosis; CLL: chronic lymphoblastic leukemia; SAA, severe...
  • dataset

    Summary of adverse events.

    †Total adverse events encompasses all intensities. Mild  =  no interference with daily activities; moderate  =  interferes with daily activities; severe  =  daily activities...
  • dataset

    Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo...

    BackgroundDoxylamine-pyridoxine is recommended as a first line treatment for nausea and vomiting during pregnancy and it is commonly prescribed. We re-analysed the findings of a...
  • dataset

    Primary and secondary outcomes.

    aIncludes acute renal failure, acute respiratory distress syndrome, heart failure, cerebral impairment (seizures, unconsciousness, motor/cognitive loss) among women who...
  • dataset

    PCEA Bolus Doses and Rescue Analgesics Administered over 48 h.

    PCEA Bolus Doses and Rescue Analgesics Administered over 48 h.
  • dataset

    Intervention effect of CETA on violence outcomes.

    Intervention effect of CETA on violence outcomes.
  • dataset

    r37980778c78--e18af7e0344729581896dd1663be1173

    Results of prespecified and reported analyses.
  • dataset

    Oral anticoagulant re-initiation following intracerebral hemorrhage in non-va...

    BackgroundWhile oral anticoagulants (OACs) are highly effective for ischemic stroke prevention in atrial fibrillation, intracerebral hemorrhage (ICH) remains the most feared...
  • dataset

    Baseline characteristics.

    *School-level deprivation uses the decile assigned to each school by the New Zealand Ministry of Education for funding purposes. It reflects the proportion of students who live...
  • dataset

    r37980778c78--63e7eeb04ceedaedac1712b10d0ae546

    Change in trichiasis severity before and after surgery among eyelids that developed post-operative trichiasis.
  • dataset

    r37980778c78--faeb20e354c372f86f67305ec6502135

    Figures are numbers of participants (percentage) unless stated otherwise.
  • dataset

    Baseline demographics and clinical characteristics.

    BMI, body mass index; i.v., intravenous; N/A, not applicable; s.c., subcutaneous; SD, standard deviation; SF-MPQ, Short-Form McGill Pain Questionnaire; VAS, visual analog scale....
  • dataset

    Clinical and inflammatory characteristics of severe asthma non-, ex-, and cur...

    Clinical and inflammatory characteristics of severe asthma non-, ex-, and current-smokers present in the bronchial brushing-transcriptomic subset.
  • dataset

    r37980778c78--a1061b2f1800c94e12c82e3ba94ca94d

    Univariate and multivariate logistic regression analyses of factors associated with therapeutic success at 3 months (n = 80).
  • dataset

    Pre-treatment characteristics of the control and intervention groups.

    Pre-treatment characteristics of the control and intervention groups.
  • dataset

    Baseline characteristics of the study population.

    Values are expressed as medians (range or percentage). * Hypertension: Yes = systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, or treated with...
  • dataset

    Factors Associated with Therapeutic Efficacy of Intravesical Onabotulinumtoxi...

    ObjectivesTo analyze the predictors of therapeutic efficacy after intravesical botulinum toxin A injection for overactive bladder syndrome (OAB) refractory to antimuscarinic...
  • dataset

    Grade 2 and higher AEs experienced by at least 5% of participants during the ...

    Grade 2 and higher AEs experienced by at least 5% of participants during the injection phase.